A model of white blood cell membrane chromatography (WB-CMC) was established to screen active component from Atractylodes macrocephala Koidz. The component can antagonize Toll-like receptor 4 (TLR4); inhibit inflammat...A model of white blood cell membrane chromatography (WB-CMC) was established to screen active component from Atractylodes macrocephala Koidz. The component can antagonize Toll-like receptor 4 (TLR4); inhibit inflammatory reaction. In the model of WB-CMC, cell membrane stationary phase (CMSP) was prepared by immobilizing the rabbit white blood cell membrane (WBCM) onto the surface of silica carrier; taxinol was used as a model molecule. The active component which can act on WBCM; its receptor (such as TLR4) as an effective target in A. macrocephala was determined by using a replacement experiment. The anti-inflammatory effects of the active component were tested by using pharmacological methods in vivo. The results indicated that the retention characteristics of atractylenolide I as active component was similar to that of taxinol in the model of WB-CMC. And so, atractylenolide I acted on the WBCM; TLR4; its anti-inflammatory activity was related with antagonizing TLR4. Therefore, the interaction between the active component; WBCM; its receptor can be simulated by the model of WB-CMC in vitro. This model can be used to screen active components; to study effective characteristics for acting on definite targets.展开更多
文摘A model of white blood cell membrane chromatography (WB-CMC) was established to screen active component from Atractylodes macrocephala Koidz. The component can antagonize Toll-like receptor 4 (TLR4); inhibit inflammatory reaction. In the model of WB-CMC, cell membrane stationary phase (CMSP) was prepared by immobilizing the rabbit white blood cell membrane (WBCM) onto the surface of silica carrier; taxinol was used as a model molecule. The active component which can act on WBCM; its receptor (such as TLR4) as an effective target in A. macrocephala was determined by using a replacement experiment. The anti-inflammatory effects of the active component were tested by using pharmacological methods in vivo. The results indicated that the retention characteristics of atractylenolide I as active component was similar to that of taxinol in the model of WB-CMC. And so, atractylenolide I acted on the WBCM; TLR4; its anti-inflammatory activity was related with antagonizing TLR4. Therefore, the interaction between the active component; WBCM; its receptor can be simulated by the model of WB-CMC in vitro. This model can be used to screen active components; to study effective characteristics for acting on definite targets.
